Cis-imidazolines

摘要

There are presented compounds of the formula or pharmaceutically acceptable salts thereof, wherein Y₁, Y₂, X₁, X₂, X₃ and R are as described in this application. These compounds are believed to inhibit MDM2-p53 interaction and as such the compounds will have anti-hyperproliferative cellular activity.